https://www.selleckchem.com/pr....oducts/pirtobrutinib
The optimal antithrombotic regimen in patients with a concomitant indication for oral anticoagulation (OAT) presenting with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI) remains unclear. To perform a network meta-analysis of all randomized controlled trials (RCTs) evaluating different antithrombotic regimens among patients with ACS or undergoing PCI requiring OAT. Network meta-analysis was performed in a frequentist framework. Antithrombotic regimens were categorized by OAC type (vit